Shares of Abbott Laboratories ABT slipped 2.00% to $124.50 Thursday, on what proved to be an all-around grim trading session ...

Abbott Laboratories closed 10.05% below its 52-week high of $141.23, which the company reached on March 4th.

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

To get a sense of who is truly in control of Abbott Laboratories (NYSE:ABT), it is important to understand the ownership structure of the business. With 79% stake, institutions possess the maximum ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and ...

Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells healthcare products. The company operates in ...

Under this category, M/S Abbott Asia Investments Limited dominates with 76.26 million shares. Local General Public grabs the ...

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other profitable dividend stocks. When it comes to profits, dividend investing is the first ...